Yucca Health vs TMates: Price, Docs, and Medication Access Compared
Quick verdict: Yucca Health is focused on lower starting prices and a tirzepatide option while TMates emphasizes a flat $199/month semaglutide price and 24/7 U.S. doctor access. This article compares Yucca Health vs TMates across price, clinician access, medication options, shipping and regulatory notes so you can decide which fits your priorities.
See Yucca Health pricing and plans
How they differ at a glance
Both platforms prescribe compounded GLP-1 medications to eligible patients in all 50 states and note that compounded medications are not FDA approved. The most distinctive differences supported by the sources are price structure, clinician availability, medication choices, shipping and turnaround, and financing options.
Distinctive difference 1: Price structure
Yucca Health advertises compounded semaglutide starting at $146/month and compounded tirzepatide from $258/month, with a 6 month semaglutide plan marketed as $875 total. TMates advertises a flat $199/month price that remains the same at every dose, with landing page tiers shown for multi month plans but a clear claim of $199/month flat. If lowest starting monthly cost is your priority, Yucca Health is presented as the lower starting price. If predictable flat per month cost regardless of dose matters more, TMates highlights that benefit.
Distinctive difference 2: Clinician access and oversight
TMates emphasizes 24/7 access to U.S. based doctors and virtual check ins. Yucca Health notes board certified providers licensed in all 50 states and a licensed clinician review process that typically issues a decision within 24 hours. Choose TMates for continuous physician availability according to the source. Choose Yucca Health if you prioritize rapid online approval within 24 hours and standard clinician review.
View TMates doctor access and details
Distinctive difference 3: Medication options
Yucca Health explicitly offers compounded tirzepatide and compounded semaglutide, stating tirzepatide activates GIP and GLP 1 receptors and is available from approximately $258/month. TMates highlights compounded semaglutide and public detail on tirzepatide availability is limited. If access to tirzepatide through the same platform is important, the source supports Yucca Health as the option that lists both medications.
Distinctive difference 4: Shipping, turnaround and financing
Yucca Health promotes fast 24 hour approvals, UPS 2 Day Air shipping and buy now pay later financing through Klarna, Afterpay, and Affirm. TMates advertises free shipping and a cancel anytime policy and focuses on steady program oversight. If BNPL options are helpful, Yucca Health documents multiple BNPL choices. If free shipping and program continuity are priorities, TMates highlights free shipping and resuming scheduled doses under provider guidance.
Comparison table: key criteria
| Criteria | Yucca Health | TMates |
|---|---|---|
| Starting price | Semaglutide from $146/month; tirzepatide from $258/month | $199/month flat at every dose |
| Clinician access | Board certified providers licensed in all 50 states; 24 hour approval typical | 24/7 U.S. doctor access; virtual check ins |
| Medication options | Compounded semaglutide and compounded tirzepatide | Compounded semaglutide; tirzepatide availability is less detailed |
| Shipping and turnaround | UPS 2 Day Air; most patients receive first shipment within 3 to 5 business days after intake | Free shipping; program continuity and scheduling guided by providers |
| Financing and payment | Klarna, Afterpay, Affirm accepted; no insurance | Direct pay model with payment options; sources note no insurance billing in general |
| Regulatory note | Compounded medications are not FDA approved and are not reviewed by FDA for safety, effectiveness or quality | |
Safety, legitimacy and expectations
Both sources state they operate with licensed providers in all 50 states and that compounded semaglutide uses the same active ingredient as branded options. Both also include the regulatory qualifier that compounded medications are not FDA approved and are not reviewed by FDA for safety, effectiveness or quality. Neither source guarantees weight loss outcomes; clinical trial averages are cited in Yucca Health materials as context for expected ranges when dosed equivalently.
Check Yucca Health plan details
Practical differences that matter
If you want the lowest advertised starting monthly cost and a listed tirzepatide program, Yucca Health presents those elements along with BNPL options and quick approvals. If you want a single flat monthly price at every dose and 24/7 access to U.S. doctors, TMates highlights those strengths. Both require clinician review and medical eligibility and both use compounded medications that are not FDA approved as finished products.
Compare TMates pricing and access
Choose one if…
Choose Yucca Health if you prioritize lower starting monthly pricing for semaglutide and explicit access to compounded tirzepatide, fast online approvals within 24 hours, UPS 2 Day Air shipping, and buy now pay later financing through Klarna, Afterpay, or Affirm.
Choose TMates if you prioritize a flat $199/month price that does not increase with dose and around the clock access to U.S. based doctors plus free shipping and scheduled virtual check ins.
Both platforms state compounded medications are not FDA approved and availability is subject to clinician review and medical eligibility. For a side by side decision, weigh price structure against clinician availability and medication choice when comparing Yucca Health vs TMates.